Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
DEFTA Partners is a venture investment organization founded in the 1980s, with offices in San Francisco, Tokyo, and Hong Kong. The firm has a diverse portfolio of 100 companies and focuses on identifying and funding innovative technologies. Their investment strategy emphasizes sustainable growth, particularly in developing regions.
DEFTA Partners primarily invests in the healthcare and information and communication technology (ICT) sectors. In healthcare, they target advanced therapeutics, health ICT, and enabling technologies. Their ICT investments are guided by a vision of pervasive ubiquitous communications (PUC), focusing on embedded devices, digital TV, and online security.
Notable portfolio companies include Aegle Therapeutics Corporation, which is developing extracellular vesicles as therapy and has received a grant from the U.S. Department of Defense for its product candidate AGLE-102. Another example is Abilitech Medical Inc., a medical-device startup that launched Abilitech Assist, a wearable technology designed to aid individuals with limited arm movement.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.